Marqeta, Inc. (MQ): what the price requires

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/MQ

Headline

Field	Value
Ticker	MQ
Company	Marqeta, Inc.
Current price	$16.42/sh

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

Field	Value
Inversion basis	revenue-multiple
EV / sales paid	10.4x
Steady-state operating margin assumed	28.0%
Must persist for	14.5y

The company earns no operating profit yet; the inversion runs on the revenue multiple and an assumed steady-state margin.

Solve inputs: computed at a 12.6% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~2.4 years.

Reconcile: at the x-ray's 9.3% required return this reads ~7.7 years; the models below use their own rates.

How unusual the bet is: elevated

Reference	Value
vs own history	-0.24σ
sustained it ~10 years at this level	15%
implied end-window share	0%

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Family	Median price/FV	Models	Reads
Asset	—	0	—
Earnings	4.61x	2	expensive
Relative	1.37x	3	expensive
Growth	0.87x	3	justifies

Families that justify the price: Growth Families that call it expensive: Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.2%); the inversion above states its own rate.

Per-Model Detail (n=8)

Model	Family	FV	Price/FV	Applicable	Methodology
DCF Perpetual Growth	Growth	$14.88	1.10x	yes	FCF base $0.2B, growth 23% (input: historical growth), terminal g 4.0%, WACC 9.2%, 7yr projection
DCF Exit Multiple	Growth	$18.91	0.87x	yes	Exit EV/EBITDA: 1320.6x / 1322.6x / 1324.6x (bear / base = today's held flat / bull), 7yr
Relative Valuation	Relative	$12.02	1.37x	yes	P/S fallback (negative EPS): Sector P/S 8.0x × TTM revenue — excluded from consensus
Simple DDM	Growth	—	—	no	—
Two-Stage DDM	Growth	—	—	no	—
Simple Excess Return	Asset	$0.05	328.40x	yes	BV/sh $1.71, ROE (TTM) 0.3%, ke 9.3% (excluded from median)
Two-Stage Excess Return	Asset	$0.03	547.33x	yes	5yr excess ROE then converge to ke=9.3% (excluded from median)
Discounted Future Market Cap	Growth	$20.18	0.81x	yes	Rev $0.7B, growth 23% (input: historical growth; tapered), Terminal P/S: 8.9x / 10.9x / 13.0x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair Value	Relative	$0.00	—	no	Negative/zero EPS — earnings-based value floored at $0
Margin Trajectory	Growth	—	—	no	—
Earnings Power Value	Earnings	—	—	no	—
Residual Income	Asset	$0.02	821.00x	yes	BV $1.71 + 5yr PV of (ROE (TTM) 0.3% − Kₑ 9.3%) × BV; BV grows 0.2%/yr (excluded from median)
Graham Number	Asset	—	—	no	—
EV/EBITDA Relative	Relative	$1.79	9.17x	yes	EBITDA $0.00B × sector EV/EBITDA 25.0x
FCF Yield	Earnings	$5.18	3.17x	yes	FCF $147.1M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF Yield	Earnings	$2.71	6.06x	yes	SBC-adj FCF $0.05B (FCF $0.15B − SBC $0.10B) capitalized at Kₑ
Ben Graham Formula	Earnings	—	—	no	—
ROIC-Justified P/B	Asset	$0.43	38.19x	yes	BV $1.71 × (ROIC 2.3% / WACC 9.2%) (excluded from median)
P/Sales Sector	Relative	$12.02	1.37x	yes	Revenue $0.65B × sector P/S 8.0x
PEG Fair Value	Relative	—	—	no	—
Earnings Yield	Earnings	—	—	no	—
Funds From Operations Multiple	Relative	—	—	no	—
Clinical Phase NPV	Growth	—	—	no	—
Merton	Asset	—	—	no	—
V5 Mechanical	—	—	—	no	—

Solvency

Field	Value
Net cash	$704.3m
Share count CAGR (buyback)	-5.5%
Burning cash	no

Operating profit is negative or near zero and the company has no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so years-to-repay cannot be computed honestly.

Operating profit is negative or near zero and there is no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so interest coverage cannot be computed honestly.

Bullet Takeaways

At $3.87 Marqeta trades around 1.6x revenue, low enough that the price sits below what even a modest revenue decline would warrant, on the assumption it eventually earns a roughly 28% operating margin. This is a profitability-conversion bet priced cautiously.

The operating story just inflected. Q1 2026 delivered the first quarter of GAAP profit, $8 million of net income, on net revenue of $165.8 million up 19% and total processing volume of $112 billion up 33%, the third straight quarter of 30%-plus volume growth.

The central risk is concentration, not the balance sheet. Marqeta holds about $704 million of net cash and essentially no debt, but a small set of customers drives most revenue, and Block alone is still about 42% of net revenue with expected declines ahead.

Bull Case

Start with the fear, because it is the whole bear case: Marqeta is too dependent on Block. The filing concedes the structure plainly, warning that "a small number of customers account for a large percentage of our net revenue" and recalling that the "August 2023 Block Amendment renewed our agreement with Block for the Cash App program on different terms, which reduced reported net revenue" (FY2025 10-K, accession 0001522540-26-000017). That is a real vulnerability and the market is right to price for it. The question is whether the recent data confirms the fear or undermines it.

The data is undermining it. Block net-revenue concentration has fallen to about 42%, down from far higher levels, and the rest of the platform is growing fast enough to absorb the expected Block softness, which management quantifies as only a 1.5% to 2% drag on full-year gross-profit growth. Q1 2026 net revenue rose 19% to $165.8 million on total processing volume up 33% to $112 billion, the third consecutive quarter of 30%-plus volume growth. A business diversifying its biggest customer down while still compounding volume in the thirties is exactly what a concentration-recovery looks like in real time.

And the model has crossed the line that matters. Q1 2026 was Marqeta's first quarter of GAAP profitability, $8 million of net income, and management raised full-year GAAP net income guidance to $15 million from $10 million on the outperformance, while guiding adjusted EBITDA growth to the mid-to-high twenties. The balance sheet funds all of it, with about $704 million of net cash, essentially no debt, and a share count down about 5.5% over the past year. The bull case is that the feared concentration is shrinking, the platform keeps scaling volume, and the company has reached self-funded profitability at a price that several methods say is below the value of even a slowly declining revenue base.

Bear Case

Begin with the capital structure, because it is the one place Marqeta looks unambiguously safe and the safety is partly illusory. The company carries about $704 million of net cash against trivial debt, so there is no solvency risk. But the operating engine that is supposed to make that cash compound is barely above breakeven: trailing operating income is negative, the current operating margin is roughly negative four percent, and the entire valuation rests on the assumption that the business eventually converts to something like a 28% operating margin. The model is explicit that there is "no demonstrated through-cycle operating margin to normalize against," so coverage and payback cannot even be computed honestly. A fortress balance sheet around a business that has only just touched profitability is a thinner cushion than it looks, and the filing notes share repurchases against this backdrop "could also affect the trading price of our stock and may reduce working capital" (FY2025 10-K, accession 0001522540-26-000017).

The structural fragility is customer concentration that has already bitten once. Block remains about 42% of net revenue, and the 2023 Block Amendment that "reduced reported net revenue" is a worked example of what happens when a dominant customer renegotiates. Marqeta expects further declines in new Block and Cash App issuances this year. Worse, the contracts are not locked: the filing warns that "some of our customer contracts provide for a termination clause" (accession 0001522540-26-000017), so even the diversified revenue carries renewal and repricing risk.

The competitive and economic backdrop compounds it. Marqeta competes against larger processors and pays its issuing banks fees "typically equal to a specified percentage of processing volume or a fixed amount per transaction," a cost structure that caps the take rate, and it warns competition "could adversely affect our ability to drive the processing volume and revenue growth that we seek" (accession 0001522540-26-000017). The bear case is not that Marqeta is failing. It is that a just-profitable, take-rate-constrained processor with a 42% customer is priced on a 28%-margin future it has not yet demonstrated, and any Block renegotiation or competitive loss would push that proof further out.

Valuation

Marqeta is not yet earning a normal operating profit, so the price is set against sales rather than earnings. At $3.87 the stock trades around 1.6x revenue, a multiple low enough that the inversion flags it as below the floor: the price sits beneath what even a 5%-a-year revenue decline would warrant, holding a terminal operating-margin assumption of about 28% (a 70% gross margin times a 40% mature-conversion prior). This is a bound, not a solved growth rate, so the honest statement is that the price is below the level a modest decline would justify, not that any particular growth number is implied.

The X-ray methods straddle the price, which fits a company at the breakeven inflection. The growth methods are mixed: DCF Perpetual Growth at $15 and Relative Valuation at $12 (an 8x sector P/S applied to revenue) sit well above the price, while DCF Exit Multiple at $6.62 and Discounted Future Market Cap at $4.76 are closer. The earnings methods are necessarily thin given near-zero operating income, with FCF yield at $5.18 and SBC-adjusted FCF yield at $2.71 bracketing the price. The reverse-DCF reasonable band lands at roughly $4.93 to $6.22, above the current quote.

The practical read is a profitability-conversion bet priced with real caution. The comparison data is limited, so the within-range label should be taken directionally. The reason the methods land above the price is the same reason they are uncertain: Marqeta has just crossed into GAAP profit and is being asked to prove it can hold and expand margin while diversifying away from Block. If it converts toward the assumed 28% operating margin, the revenue-multiple methods say the equity is worth more than $3.87. If margin stalls or Block re-prices again, the thin current operating profit is the warning that the conversion is a forecast, not a track record.

Catalysts

The Q1 2026 print, reported in May 2026, was the pivotal recent event: Marqeta's first quarter of GAAP profitability with $8 million of net income, net revenue of $165.8 million up 19%, and total processing volume of $112 billion up 33%, the third straight quarter of 30%-plus volume growth (StockTitan; Investing.com). Management raised full-year GAAP net income guidance to $15 million from $10 million and reaffirmed 12% to 14% net-revenue growth, 10% to 12% gross-profit growth, and adjusted EBITDA growth in the mid-to-high twenties (Seeking Alpha).

The forward set is dominated by the Block transition and margin proof. Block concentration has fallen to about 42%, but the company expects some decline in new Block and Cash App issuances during the year, a headwind it sizes at 1.5% to 2% of gross-profit growth. The swing factors into the next prints are continued diversification away from Block, whether TPV growth holds in the thirties, the pace of operating-margin expansion now that the business is GAAP-profitable, and any renewal or repricing of large customer contracts. Management has framed 2026 as an operating-leverage proof point rather than a revenue-acceleration story.

Sources: Marqeta Q1 2026 results (StockTitan; Investing.com; MQ 8-K, 2026); Seeking Alpha guidance coverage; Motley Fool earnings transcript (2026).

Peer Cohorts (Per Segment, With Filing Citations)

Card issuing platform (consolidated) (reported)

• ALKT (ALKAMI TECHNOLOGY, INC.)
• (no filing in the citation store)
• GLBE (Global-E Online Ltd.)
• (no filing in the citation store)
• BILL (BILL HOLDINGS, INC.)
• (no filing in the citation store)
• XYZ (Block, Inc.)
• (no filing in the citation store)
• TOST (Toast, Inc.)
• (no filing in the citation store)
• EVTC (EVERTEC, Inc.)
• (no filing in the citation store)
• JKHY (JACK HENRY & ASSOCIATES, INC.)
• (no filing in the citation store)

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.